ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Using the Remuzzi Score to Guide Single vs. Dual Transplantation Mitigates the Risk of Early Graft Failure

    J. Ayorinde, G. Pettigrew.

    Surgery, University of Cambridge, Cambridge, United Kingdom.

    BackgroundExpanded criteria circulatory death donors (DCD) may represent an underutilised donor pool. Our centre has used urgent pre-implantation biopsy (Remuzzi score) to guide single (SKT)…
  • 2018 American Transplant Congress

    Use of Perfusion Machine after Long Cold Ischemia Time: 3 Years Results

    A. Matos,1 L. Requião-Moura,1 E. Tonato,1 M. Souza-Durão,1,2 M. Borrelli,1 M. Nogueira,1 P. Rubio,1 A. Pacheco-Silva.1,2

    1Transplant, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil.

    The rate of delayed graft function (DGF) in Brazil is very high, reaching 80%. This is due to the long cold ischemia time (TIF) and…
  • 2018 American Transplant Congress

    Clinical Outcomes of HIV-Infected Kidney Transplant Recipients Managed with an Early Corticosteroid Withdrawal Protocol

    A. Al Jurdi, E. Liu, M. Aull, M. Lubetsky, D. Serur, S. Kapur, T. Muthukumar.

    Weill Cornell Medicine / New York Presbyterian Hospital, New York.

    AimAssess the clinical outcomes of HIV-infected kidney transplant recipients managed with an early corticosteroid withdrawal protocol.MethodsSingle center chart review of HIV-infected kidney recipients between 2006…
  • 2018 American Transplant Congress

    Technical Challenges in Living Donor Kidney Transplantation – Diagnosis and Solutions

    R. Öllinger,1 K. Alqasim,1 F. Klein,1 N. Raschzok,1 P. Ritschl,1 S. Chopra,1 N. Otto,2 T. Denecke,3 U. Gerlach,1 M. Schmelzle,1 P. Reinke,2 J. Pratschke.1

    1Department of Surgery, Charité, Berlin, Germany; 2Department of Nephrology, Charité, Berlin, Germany; 3Department of Radiology, Charité, Berlin, Germany.

    IntroductionDue to organ scarcity living donation is becoming a major source of kidneys for transplantation. Besides medical contraindications, anatomy of the kidneys may be a…
  • 2018 American Transplant Congress

    Polymorphisms of Nucleotide Factor of Activated T Cells Cytoplasmic 2 and 4 and the Risk of Acute Rejection Following Kidney Transplantation

    Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.

    Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

    Background: Acute rejection (AR) is a common complication of kidney transplantation. Nuclear factors of activated T cells (NFATs) are transcription factors involved in the activation…
  • 2018 American Transplant Congress

    No Deleterious Effect from the Presence of Donor Specific Antibodies (DSA) or Positive Flow Cytometry Crossmatch (FCXM) on the Outcomes of Simultaneous Liver-Kidney (SLK) Transplant Recipients

    H. Khamash, A. Kumar, B. Aqel, R. Heilman, A. Jaramillo, K. Reddy, A. Moss.

    Mayo Clinic Arizona, Phoenix.

    SLK transplant recipients have excellent outcomes that rival kidney alone recipients in terms of graft and patient survival and have better outcomes in terms of…
  • 2018 American Transplant Congress

    Medical and Psychosocial Outcomes of Directed and Non Directed Living Liver Donors

    J. Steel, S. Ganesh, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, K. Kingsley, M. Dulovich, A. Tevar, C. Hughes, A. Humar.

    Surgery, University of Pittsburgh, Pittsburgh, PA.

    Background: Few transplant centers accept Good Samaritan living liver donors. The aims of this study were to compare the medical and psychosocial outcomes of directed…
  • 2018 American Transplant Congress

    Water-Jet Dissection for Donor Hepatectomy during Living Donor Liver Transplantation

    K. Gotoh,1 H. Eguchi,1 Y. Iwagami,1 D. Yamada,1 T. Asaoka,1 T. Noda,1 K. Kawamoto,1 S. Kobayashi,1 K. Umeshita,2 Y. Doki,1 M. Mori.1

    1Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan; 2Health Science, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

    Background The most important issue in living donor liver transplantation (LDLT) is donor safety. Although donor hepatectomy has evolved technically over the years, it is…
  • 2018 American Transplant Congress

    Extracellular Vesicles Derived from Huc-MSCs Alleviate Rat Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Neutrophil Inflammatory Response

    J. Yao,1,2 J. Cai,1,2 J. Zheng,1,2 L. Chen,1,2 Y. Zhang,1,2 Y. Yang.1,2

    1Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital, Organ Transplantation Institute, Guangzhou, Guangdong, China; 2Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, .

    Mesenchymal stem cells (MSCs) have been reported possessing therapeutic effects on immunoregulation, tissue repair and regeneration from bench to bedside. Extracellular vesicles (EVs) derived from…
  • 2018 American Transplant Congress

    An Open-Label Proof-of-Principle Phase 2a Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

    A. Chruscinski,1 H. Atkins,2 M. Macarthur,1 C. Anne Marie,2 D. Grant,1 C. Bredsen,2 E. Renner,1 L. Lilly,1 N. Selzner,1 O. Adeyi,1 R. Smith,1 S. Moshkelgosha,1 A. Humar,1 S. Juvet,1 G. Levy.1

    1Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada; 2Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.

    Background: Long-term survival of recipients of solid organ transplants is hampered by chronic rejection, disease recurrence and immunosuppression-induced toxicity. Self-tolerance is re-established after autologous hematopoietic…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences